XML 144 R42.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidating Financial Statements of Aramark and Subsidiaries (Tables)
12 Months Ended
Sep. 27, 2019
Condensed Financial Information Disclosure [Abstract]  
Schedule of Condensed Consolidated Balance Sheet
CONDENSED CONSOLIDATING BALANCE SHEETS
September 27, 2019
(in thousands)
 
Aramark
(Parent)
 
Issuers
 
Guarantors
 
Non Guarantors
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
5

 
$
33,510

 
$
40,544

 
$
172,584

 
$

 
$
246,643

Receivables

 
1,966

 
522,627

 
1,282,371

 

 
1,806,964

Inventories

 
15,804

 
301,091

 
94,424

 

 
411,319

Prepayments and other current assets

 
27,164

 
82,666

 
83,631

 

 
193,461

Total current assets
5

 
78,444

 
946,928

 
1,633,010

 

 
2,658,387

Property and Equipment, net

 
43,329

 
1,784,410

 
354,023

 

 
2,181,762

Goodwill

 
173,104

 
4,694,549

 
651,147

 

 
5,518,800

Investment in and Advances to Subsidiaries
3,320,042

 
6,649,119

 

 
717,228

 
(10,686,389
)
 

Other Intangible Assets

 
29,684

 
1,819,315

 
184,567

 

 
2,033,566

Other Assets

 
20,382

 
979,350

 
346,076

 
(2,002
)
 
1,343,806

 
$
3,320,047

 
$
6,994,062

 
$
10,224,552

 
$
3,886,051

 
$
(10,688,391
)
 
$
13,736,321

LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Current maturities of long-term borrowings
$

 
$
6,256

 
$
27,924

 
$
35,748

 
$

 
$
69,928

Accounts payable

 
127,640

 
507,903

 
363,974

 

 
999,517

Accrued expenses and other current liabilities

 
241,523

 
1,030,074

 
364,168

 
88

 
1,635,853

Total current liabilities

 
375,419

 
1,565,901

 
763,890

 
88

 
2,705,298

Long-term Borrowings

 
6,090,487

 
82,394

 
439,358

 

 
6,612,239

Deferred Income Taxes and Other Noncurrent Liabilities

 
380,453

 
569,409

 
138,960

 

 
1,088,822

Intercompany Payable

 

 
4,187,591

 
726,464

 
(4,914,055
)
 

Redeemable Noncontrolling Interest

 

 
9,915

 

 

 
9,915

Total Stockholders' Equity
3,320,047

 
147,703

 
3,809,342

 
1,817,379

 
(5,774,424
)
 
3,320,047

 
$
3,320,047

 
$
6,994,062

 
$
10,224,552

 
$
3,886,051

 
$
(10,688,391
)
 
$
13,736,321


CONDENSED CONSOLIDATING BALANCE SHEETS
September 28, 2018
(in thousands)
 
 
Aramark
(Parent)
 
Issuers
 
Guarantors 
 
Non Guarantors
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
 
Current Assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
5

 
$
50,716

 
$
29,844

 
$
134,460

 
$

 
$
215,025

Receivables

 
1,038

 
443,599

 
1,345,796

 

 
1,790,433

Inventories

 
15,857

 
592,259

 
116,686

 

 
724,802

Prepayments and other current assets

 
21,411

 
86,100

 
63,654

 

 
171,165

Total current assets
5

 
89,022

 
1,151,802

 
1,660,596

 

 
2,901,425

Property and Equipment, net

 
28,341

 
1,013,523

 
336,230

 

 
1,378,094

Goodwill

 
173,104

 
4,783,547

 
653,917

 

 
5,610,568

Investment in and Advances to Subsidiaries
3,029,553

 
7,441,605

 
90,049

 
844,245

 
(11,405,452
)
 

Other Intangible Assets

 
29,684

 
1,919,795

 
187,365

 

 
2,136,844

Other Assets

 
100,754

 
1,264,976

 
329,443

 
(2,002
)
 
1,693,171

 
$
3,029,558

 
$
7,862,510

 
$
10,223,692

 
$
4,011,796

 
$
(11,407,454
)
 
$
13,720,102

LIABILITIES AND 
STOCKHOLDERS' EQUITY
 
 
 
 
 
 
 
 
 
 
 
Current Liabilities:
 
 
 
 
 
 
 
 
 
 
 
Current maturities of long-term borrowings
$

 
$

 
$
26,564

 
$
4,343

 
$

 
$
30,907

Accounts payable

 
128,460

 
483,606

 
406,854

 

 
1,018,920

Accrued expenses and other current liabilities

 
205,807

 
926,794

 
307,643

 
88

 
1,440,332

Total current liabilities

 
334,267

 
1,436,964

 
718,840

 
88

 
2,490,159

Long-term Borrowings

 
6,651,110

 
82,097

 
479,870

 

 
7,213,077

Deferred Income Taxes and Other Noncurrent Liabilities

 
432,583

 
466,331

 
78,301

 

 
977,215

Intercompany Payable

 

 
4,827,084

 
955,407

 
(5,782,491
)
 

Redeemable Noncontrolling Interest

 

 
10,093

 

 

 
10,093

Total Stockholders' Equity
3,029,558

 
444,550

 
3,401,123

 
1,779,378

 
(5,625,051
)
 
3,029,558

 
$
3,029,558

 
$
7,862,510

 
$
10,223,692

 
$
4,011,796

 
$
(11,407,454
)
 
$
13,720,102



Schedule of Condensed Consolidated Statement of Income
CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
For the year ended September 27, 2019
(in thousands)
 
 
Aramark
(Parent)
 
Issuers
 
Guarantors 
 
Non Guarantors
 
Eliminations
 
Consolidated
Revenue
$

 
$
1,062,655

 
$
10,653,013

 
$
4,511,673

 
$

 
$
16,227,341

Costs and Expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of services provided

 
981,661

 
9,362,232

 
4,188,769

 

 
14,532,662

Depreciation and amortization

 
16,377

 
473,833

 
102,363

 

 
592,573

Selling and general corporate expenses

 
162,963

 
176,714

 
27,579

 

 
367,256

Gain on sale of Healthcare Technologies

 

 
(156,309
)
 

 

 
(156,309
)
Interest and other financing costs, net

 
316,120

 
3,531

 
15,336

 

 
334,987

Expense allocations

 
(315,432
)
 
274,501

 
40,931

 

 

 

 
1,161,689

 
10,134,502

 
4,374,978

 

 
15,671,169

Income (Loss) before Income Taxes

 
(99,034
)
 
518,511

 
136,695

 

 
556,172

Provision (Benefit) for Income Taxes

 
(38,388
)
 
109,144

 
36,950

 

 
107,706

Equity in Net Income of Subsidiaries
448,549

 

 

 

 
(448,549
)
 

Net income (loss)
448,549

 
(60,646
)
 
409,367

 
99,745

 
(448,549
)
 
448,466

Less: Net loss attributable to noncontrolling interest

 

 
(83
)
 

 

 
(83
)
Net income (loss) attributable to Aramark stockholders
448,549

 
(60,646
)
 
409,450

 
99,745

 
(448,549
)
 
448,549

Other comprehensive income (loss), net of tax
(125,742
)
 
(71,282
)
 
(553
)
 
(121,505
)
 
193,340

 
(125,742
)
Comprehensive income (loss) attributable to Aramark stockholders
$
322,807

 
$
(131,928
)
 
$
408,897

 
$
(21,760
)
 
$
(255,209
)
 
$
322,807


CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
For the year ended September 28, 2018
(in thousands)
 
Aramark
(Parent)
 
Issuers
 
Guarantors 
 
Non Guarantors
 
Eliminations
 
Consolidated
Revenue
$

 
$
1,027,573

 
$
10,432,088

 
$
4,329,972

 
$

 
$
15,789,633

Costs and Expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of services provided

 
848,739

 
9,132,991

 
4,016,181

 

 
13,997,911

Depreciation and amortization

 
19,466

 
483,106

 
93,610

 

 
596,182

Selling and general corporate expenses

 
195,093

 
158,064

 
23,972

 

 
377,129

Interest and other financing costs, net

 
329,027

 
266

 
17,242

 

 
346,535

Expense allocations

 
(374,970
)
 
353,628

 
21,342

 

 

 

 
1,017,355

 
10,128,055

 
4,172,347

 

 
15,317,757

Income before Income Taxes

 
10,218

 
304,033

 
157,625

 

 
471,876

Provision (Benefit) for Income Taxes

 
(3,521
)
 
(143,452
)
 
50,409

 

 
(96,564
)
Equity in Net Income of Subsidiaries
567,885

 

 

 

 
(567,885
)
 

Net income
567,885

 
13,739

 
447,485

 
107,216

 
(567,885
)
 
568,440

Less: Net income attributable to noncontrolling interest

 

 
555

 

 

 
555

Net income attributable to Aramark stockholders
567,885

 
13,739

 
446,930

 
107,216

 
(567,885
)
 
567,885

Other comprehensive income (loss), net of tax
32,537

 
43,686

 
3,178

 
(36,776
)
 
(10,088
)
 
32,537

Comprehensive income attributable to Aramark stockholders
$
600,422

 
$
57,425

 
$
450,108

 
$
70,440

 
$
(577,973
)
 
$
600,422


CONDENSED CONSOLIDATING STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
For the year ended September 29, 2017
(in thousands)

 
Aramark
(Parent)
 
Issuers
 
Guarantors 
 
Non Guarantors
 
Eliminations
 
Consolidated
Revenue
$

 
$
1,041,490

 
$
9,708,157

 
$
3,854,765

 
$

 
$
14,604,412

Costs and Expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of services provided

 
941,031

 
8,507,705

 
3,546,667

 

 
12,995,403

Depreciation and amortization

 
17,502

 
416,979

 
73,731

 

 
508,212

Selling and general corporate expenses

 
140,305

 
138,304

 
20,561

 

 
299,170

Interest and other financing costs, net

 
273,405

 
(3,196
)
 
10,776

 

 
280,985

Expense allocations

 
(348,042
)
 
318,199

 
29,843

 

 

 

 
1,024,201

 
9,377,991

 
3,681,578

 

 
14,083,770

Income Before Income Taxes

 
17,289

 
330,166

 
173,187

 

 
520,642

Provision for Income Taxes

 
5,139

 
98,144

 
43,172

 

 
146,455

Equity in Net Income of Subsidiaries
373,923

 

 

 

 
(373,923
)
 

Net income
373,923

 
12,150

 
232,022

 
130,015

 
(373,923
)
 
374,187

Less: Net income attributable to noncontrolling interest

 

 
264

 

 

 
264

Net income attributable to Aramark stockholders
373,923

 
12,150

 
231,758

 
130,015

 
(373,923
)
 
373,923

Other comprehensive income, net of tax
57,023

 
35,667

 
431

 
80,204

 
(116,302
)
 
57,023

Comprehensive income attributable to Aramark stockholders
$
430,946

 
$
47,817

 
$
232,189

 
$
210,219

 
$
(490,225
)
 
$
430,946



Schedule of Condensed Consolidated Cash Flow Statement
CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
For the year ended September 27, 2019
(in thousands)

 
Aramark
(Parent)
 
Issuers
 
Guarantors 
 
Non Guarantors
 
Eliminations
 
Consolidated
Net cash provided by (used in) operating activities
$

 
$
(47,231
)
 
$
757,832

 
$
290,539

 
$
(16,913
)
 
$
984,227

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Purchases of property and equipment and other

 
(12,160
)
 
(414,017
)
 
(76,913
)
 

 
(503,090
)
Disposals of property and equipment

 
6,644

 
6,665

 
4,562

 

 
17,871

Proceeds from divestiture

 

 
293,711

 

 

 
293,711

Acquisitions of businesses, net of cash acquired

 

 
(23,028
)
 
(21,835
)
 

 
(44,863
)
Proceeds from government agencies related to property and equipment

 

 
23,025

 

 

 
23,025

Other investing activities

 
(356
)
 
3,677

 
504

 

 
3,825

Net cash used in investing activities

 
(5,872
)
 
(109,967
)
 
(93,682
)
 

 
(209,521
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Proceeds from long-term borrowings

 

 

 
77,630

 

 
77,630

Payments of long-term borrowings

 
(545,809
)
 
(34,431
)
 
(74,320
)
 

 
(654,560
)
Payments of dividends

 
(108,439
)
 

 

 

 
(108,439
)
Proceeds from issuance of common stock

 
39,087

 

 

 

 
39,087

Repurchase of common stock

 
(50,000
)
 

 

 

 
(50,000
)
Other financing activities

 
(36,305
)
 
(2,192
)
 
(113
)
 

 
(38,610
)
Change in intercompany, net

 
737,363

 
(600,542
)
 
(153,734
)
 
16,913

 

Net cash provided by (used in) financing activities

 
35,897

 
(637,165
)
 
(150,537
)
 
16,913

 
(734,892
)
Effect of foreign exchange rates on cash and cash equivalents

 

 

 
(8,196
)
 

 
(8,196
)
Decrease (increase) in cash and cash equivalents

 
(17,206
)
 
10,700

 
38,124

 

 
31,618

Cash and cash equivalents, beginning of period
5

 
50,716

 
29,844

 
134,460

 

 
215,025

Cash and cash equivalents, end of period
$
5

 
$
33,510

 
$
40,544

 
$
172,584

 
$

 
$
246,643


CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
For the year ended September 28, 2018
(in thousands)

 
Aramark
(Parent)
 
Issuers
 
Guarantors 
 
Non Guarantors
 
Eliminations
 
Consolidated
Net cash provided by operating activities
$

 
$
111,541

 
$
690,218

 
$
315,703

 
$
(65,587
)
 
$
1,051,875

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Purchases of property and equipment other

 
(13,133
)
 
(532,923
)
 
(82,548
)
 

 
(628,604
)
Disposals of property and equipment

 
2,252

 
4,301

 
3,938

 

 
10,491

Acquisitions of businesses, net of cash acquired

 
(2,381,800
)
 
244,581

 
(103,065
)
 

 
(2,240,284
)
Other investing activities

 
(3,095
)
 
328

 
(4,112
)
 

 
(6,879
)
Net cash used in investing activities

 
(2,395,776
)
 
(283,713
)
 
(185,787
)
 

 
(2,865,276
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Proceeds from long-term borrowings

 
3,012,072

 

 
165,241

 

 
3,177,313

Payments of long-term borrowings

 
(833,854
)
 
(28,142
)
 
(111,693
)
 

 
(973,689
)
Net change in funding under the Receivables Facility

 

 

 
(254,200
)
 

 
(254,200
)
Payments of dividends

 
(103,115
)
 

 

 

 
(103,115
)
Proceeds from issuance of common stock

 
21,507

 

 

 

 
21,507

Repurchase of common stock

 
(24,410
)
 

 

 

 
(24,410
)
Other financing activities

 
(45,905
)
 
(2,958
)
 
(390
)
 

 
(49,253
)
Change in intercompany, net

 
197,144

 
(383,074
)
 
120,343

 
65,587

 

Net cash provided by (used in) financing activities

 
2,223,439

 
(414,174
)
 
(80,699
)
 
65,587

 
1,794,153

Effect of foreign exchange rates on cash and cash equivalents

 

 

 
(4,524
)
 

 
(4,524
)
(Decrease) increase in cash and cash equivalents

 
(60,796
)
 
(7,669
)
 
44,693

 

 
(23,772
)
Cash and cash equivalents, beginning of period
5

 
111,512

 
37,513

 
89,767

 

 
238,797

Cash and cash equivalents, end of period
$
5

 
$
50,716

 
$
29,844

 
$
134,460

 
$

 
$
215,025


CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS
For the year ended September 29, 2017
(in thousands)
 
 
Aramark
(Parent)
 
Issuers
 
Guarantors 
 
Non Guarantors
 
Eliminations
 
Consolidated
Net cash provided by operating activities
$

 
$
261,282

 
$
779,801

 
$
200,018

 
$
(188,275
)
 
$
1,052,826

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Purchases of property and equipment and other

 
(20,939
)
 
(443,262
)
 
(88,528
)
 

 
(552,729
)
Disposals of property and equipment

 
494

 
14,780

 
3,632

 

 
18,906

Acquisitions of businesses, net of cash acquired

 

 
(37,130
)
 
(104,992
)
 

 
(142,122
)
Other investing activities

 
(69,401
)
 
36,946

 
29,916

 

 
(2,539
)
Net cash used in investing activities

 
(89,846
)
 
(428,666
)
 
(159,972
)
 

 
(678,484
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 

 
 
Proceeds from long-term borrowings

 
3,451,164

 

 
400,253

 

 
3,851,417

Payments of long-term borrowings

 
(3,572,268
)
 
(19,851
)
 
(319,873
)
 

 
(3,911,992
)
Net change in funding under the Receivables Facility

 

 

 
(13,800
)
 

 
(13,800
)
Payments of dividends

 
(100,813
)
 

 

 

 
(100,813
)
Proceeds from issuance of common stock

 
28,779

 

 

 

 
28,779

Repurchase of common stock

 
(100,000
)
 

 

 

 
(100,000
)
Other financing activities

 
(69,172
)
 
(2,973
)
 
29,868

 

 
(42,277
)
Change in intercompany, net

 
254,536

 
(322,142
)
 
(120,669
)
 
188,275

 

Net cash used in financing activities

 
(107,774
)
 
(344,966
)
 
(24,221
)
 
188,275

 
(288,686
)
Effect of foreign exchange rates on cash and cash equivalents

 

 

 
561

 

 
561

Increase in cash and cash equivalents

 
63,662

 
6,169

 
16,386

 

 
86,217

Cash and cash equivalents, beginning of period
5

 
47,850

 
31,344

 
73,381

 

 
152,580

Cash and cash equivalents, end of period
$
5

 
$
111,512

 
$
37,513

 
$
89,767

 
$

 
$
238,797